Low-dose sulbactam-durlobactam for recurrent CRAB pneumonia in a child with cerebral palsy: a Case Report from a resource-limited setting
Frontiers in Pharmacology · 24.08.2026 · 17
DOI: 10.3389/fphar.2026.1905442 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 24.08.2026. Verfasst von Mengting Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Ministry of Education Key Laboratory of Women and Children's Diseases and Birth Defects, West China Second University Hospi…. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pediatric data for sulbactam-durlobactam (SUL-DUR) are extremely scarce, and no standard pediatric dosing exists.
Methods
We report a 6-year-old boy with cerebral palsy and epilepsy who developed recurrent ventilator-associated pneumonia caused by OXA-23-producing carbapenem-resistant Acinetobacter baumannii (CRAB).
Results
Due to financial constraints, a reduced-dose SUL-DUR regimen (150 mg/kg/day, q6h, 3-h infusion) was combined with cefoperazone-sulbactam to achieve a total sulbactam dose of 150 mg/kg/day. The patient defervesced within 48 h, inflammatory markers declined, chest imaging improved markedly, and he was transferred out of the PICU after 12 days of therapy.
Conclusion
A PK/PD-driven low-dose SUL-DUR strategy may represent a feasible and potential cost-saving strategy for pediatric CRAB pneumonia in resource-limited settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Ministry of Education Key Laboratory of Women and Children's Diseases and Birth Defects, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
- Department of Pediatrics, WCSUH-Tianfu·Sichuan Provincial Children's Hospital, Meishan, Sichuan, China.
Zitieren
APA
Li, M., Fei, H., Huang, L., Qing, L., Liu, X., & Lu, G. (2026). Low-dose sulbactam-durlobactam for recurrent CRAB pneumonia in a child with cerebral palsy: a Case Report from a resource-limited setting. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1905442
Vancouver
Li M, Fei H, Huang L, Qing L, Liu X, Lu G. Low-dose sulbactam-durlobactam for recurrent CRAB pneumonia in a child with cerebral palsy: a Case Report from a resource-limited setting. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1905442
BibTeX
@article{Li2026,
author = {Li, Mengting and Fei, Haotian and Huang, Liang and Qing, Lu and Liu, Xiaoliang and Lu, Guoyan},
title = {Low-dose sulbactam-durlobactam for recurrent CRAB pneumonia in a child with cerebral palsy: a Case Report from a resource-limited setting},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1905442}
}
EUVIMED